Havenga M - Search Results

1

A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells.

Marzio G, Kerkvliet E, Bogaards JA, Koelewijn S, De Groot A, Gijsbers L, Weverling GJ, Vogels R, Havenga M, Custers J, Pau MG, Guichoux JY, Lewis J, Goudsmit J. Marzio G, et al. Among authors: havenga m. Vaccine. 2007 Mar 8;25(12):2228-37. doi: 10.1016/j.vaccine.2006.12.011. Epub 2006 Dec 28. Vaccine. 2007. PMID: 17250936

2

Quantification of residual host cell DNA in adenoviral vectors produced on PER.C6 cells.

Gijsbers L, Koel B, Weggeman M, Goudsmit J, Havenga M, Marzio G. Gijsbers L, et al. Among authors: havenga m. Hum Gene Ther. 2005 Mar;16(3):393-8. doi: 10.1089/hum.2005.16.393. Hum Gene Ther. 2005. PMID: 15812234

3

Suitability of PER.C6 cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics.

Koudstaal W, Hartgroves L, Havenga M, Legastelois I, Ophorst C, Sieuwerts M, Zuijdgeest D, Vogels R, Custers J, de Boer-Luijtze E, de Leeuw O, Cornelissen L, Goudsmit J, Barclay W. Koudstaal W, et al. Among authors: havenga m. Vaccine. 2009 Apr 28;27(19):2588-93. doi: 10.1016/j.vaccine.2009.02.033. Epub 2009 Feb 20. Vaccine. 2009. PMID: 19428865

4

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity.

Vogels R, Zuijdgeest D, van Rijnsoever R, Hartkoorn E, Damen I, de Béthune MP, Kostense S, Penders G, Helmus N, Koudstaal W, Cecchini M, Wetterwald A, Sprangers M, Lemckert A, Ophorst O, Koel B, van Meerendonk M, Quax P, Panitti L, Grimbergen J, Bout A, Goudsmit J, Havenga M. Vogels R, et al. Among authors: havenga m. J Virol. 2003 Aug;77(15):8263-71. doi: 10.1128/jvi.77.15.8263-8271.2003. J Virol. 2003. PMID: 12857895 Free PMC article.

5

Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine.

Samina I, Havenga M, Koudstaal W, Khinich Y, Koldijk M, Malkinson M, Simanov M, Perl S, Gijsbers L, Weverling GJ, Uytdehaag F, Goudsmit J. Samina I, et al. Among authors: havenga m. Vaccine. 2007 Nov 28;25(49):8338-45. doi: 10.1016/j.vaccine.2007.09.055. Epub 2007 Oct 15. Vaccine. 2007. PMID: 17977629

6

Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity.

Lemckert AA, Sumida SM, Holterman L, Vogels R, Truitt DM, Lynch DM, Nanda A, Ewald BA, Gorgone DA, Lifton MA, Goudsmit J, Havenga MJ, Barouch DH. Lemckert AA, et al. Among authors: havenga mj. J Virol. 2005 Aug;79(15):9694-701. doi: 10.1128/JVI.79.15.9694-9701.2005. J Virol. 2005. PMID: 16014931 Free PMC article.

7

Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity.

Lemckert AAC, Grimbergen J, Smits S, Hartkoorn E, Holterman L, Berkhout B, Barouch DH, Vogels R, Quax P, Goudsmit J, Havenga MJE. Lemckert AAC, et al. J Gen Virol. 2006 Oct;87(Pt 10):2891-2899. doi: 10.1099/vir.0.82079-0. J Gen Virol. 2006. PMID: 16963747

8

Increased immunogenicity of recombinant Ad35-based malaria vaccine through formulation with aluminium phosphate adjuvant.

Ophorst OJ, Radosević K, Klap JM, Sijtsma J, Gillissen G, Mintardjo R, van Ooij MJ, Holterman L, Companjen A, Goudsmit J, Havenga MJ. Ophorst OJ, et al. Among authors: havenga mj. Vaccine. 2007 Aug 29;25(35):6501-10. doi: 10.1016/j.vaccine.2007.06.019. Epub 2007 Jun 29. Vaccine. 2007. PMID: 17646036

9

High-level expression from two independent expression cassettes in replication-incompetent adenovirus type 35 vector.

Vogels R, Zuijdgeest D, van Meerendonk M, Companjen A, Gillissen G, Sijtsma J, Melis I, Holterman L, Radosevic K, Goudsmit J, Havenga MJE. Vogels R, et al. Among authors: havenga mje. J Gen Virol. 2007 Nov;88(Pt 11):2915-2924. doi: 10.1099/vir.0.83119-0. J Gen Virol. 2007. PMID: 17947512

10

Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors.

Sprangers MC, Lakhai W, Koudstaal W, Verhoeven M, Koel BF, Vogels R, Goudsmit J, Havenga MJ, Kostense S. Sprangers MC, et al. Among authors: havenga mj. J Clin Microbiol. 2003 Nov;41(11):5046-52. doi: 10.1128/JCM.41.11.5046-5052.2003. J Clin Microbiol. 2003. PMID: 14605137 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

105 results

Search Page